Gemcitabine and cisplatin combined with the Chinese herbal medicine compound Fuzhenggubenfang improve quality of life and progression-free survival in patients with advanced non-small cell lung cancer

Journal Title: Traditional Medicine Research - Year 2018, Vol 3, Issue 1

Abstract

Objective: To assess the role of chemotherapy combined with the compound Chinese herbal medicine, Fuzhenggubenfang (FZGBF), for treating advanced non-small-cell lung cancer. Methods: A total of 84 eligible patients were enrolled from October 2013 to July 2016. Patients were randomized to receive either chemotherapy alone as the control group or chemotherapy combined with FZGBF as the experimental group. The primary endpoint of the study was quality of life (QOL) and progression-free survival (PFS). Secondary endpoints were tumor response rate, toxicity, dropout rate, and univariate and multivariate analyses of clinicopathologic factors for QOL and PFS. Results: There was a significant improvement in QOL, including better overall health (P < 0.001), physical function (P < 0.001), role function (P < 0.001), emotional function (P < 0.001), cognitive function (P < 0.001), and social function (P = 0.031). Less fatigue, nausea or vomiting, insomnia, appetite loss, constipation, and alopecia were noted (All P < 0.001) when FZGBF was combined with chemotherapy in comparison to chemotherapy alone. The experimental group had a better PFS compared with the control group (P = 0.032). There was no significant difference in tumor response rate. FZGBF significantly reduced chemotherapy-induced anemia (P < 0.001), neutropenia (P = 0.023), nausea and vomiting (P < 0.001). The use of Chinese herbal compounds had only mild side effects. In this study, factors influencing QOL were the use of the Chinese herbal compounds (P < 0.001), performance status score (P = 0.027), clinical staging of cancer (P = 0.009), and sex (P = 0.044). Use of traditional Chinese medicine (P = 0.043) and the number of previous chemotherapy sessions (P = 0.003) were the factors influencing PFS in this study. Conclusion: FZGBF could improve QOL, compliance to treatment, relieved chemotherapy-related toxicities of patients, and consequently improved PFS, which is a promising drug combination in complementary medicine for the treatment of advanced NSCLC.

Authors and Affiliations

Dong-Mei Jiang, Feng-Wei Wang, Li-Juan Zhang, Long Zhang, Tai Zhang, Wen-Hua Zhang

Keywords

Related Articles

Application of nanoparticles in the early diagnosis and treatment of tumors: current status and progress

Objective: Malignant tumors pose a serious threat to human life and health. Despite recent developments in modern medical techniques, the early diagnosis and treatment of tumors remain difficult due to their asymptomatic...

Research on Xijiao Dihuang Decoction suppressing platelet apoptosis in immune-mediated aplastic anemia based on mitochondrial mediated pathway

The aplastic anemia mice model was established in this study. BALB/c mice shall be treated with whole body irradiation with 60 Co-γradiation (5.5Gy, 1.1Gy/min × 5 min). then within 4 h, DBA/2 mice were injected lymphocyt...

The gap between clinical practice and limited evidence of traditional Chinese medicine for COVID-19

Traditional Chinese medicine (TCM) is the set of knowledge and practices concerning life, health, illness prevention, and treatment that originated in China thousands of years ago. Presently, TCM is still one of the ma...

The riddles of number nine in Chinese medicine processing method

The “nine cycles of steaming and shining”, “nine making”, “nine turns” and “nine cycles of calcining and quenching” methods that are recorded and used since ancient times are merely one aspect of the unique processing me...

The neuroprotective role of Panax notoginseng saponins in APP/PS1 transgenic mice through the modulation of cerebrovascular

Background: Panax notoginseng saponins (PNS) is extracted from Sanqi (Panax notoginseng), which is a valuable herb and has been widely used in traditional Chinese medicine for the treatment of cerebrovascular diseases an...

Download PDF file
  • EP ID EP45246
  • DOI 10.12032/TMR201809063
  • Views 262
  • Downloads 0

How To Cite

Dong-Mei Jiang, Feng-Wei Wang, Li-Juan Zhang, Long Zhang, Tai Zhang, Wen-Hua Zhang (2018). Gemcitabine and cisplatin combined with the Chinese herbal medicine compound Fuzhenggubenfang improve quality of life and progression-free survival in patients with advanced non-small cell lung cancer. Traditional Medicine Research, 3(1), -. https://europub.co.uk/articles/-A-45246